Coeptis Therapeutics Holdings, Inc. announced that it has entered into a definitive agreement with a single healthcare focused investor for the issuance and sale of an aggregate of 2,000,000 shares of its common stock and accompanying class A warrants and class B warrants for the gross proceeds of $2,000,000, before deducting the placement agent's fees and other offering expenses payable by the company on October 24, 2023. The warrants will have an exercise price $1.36 per share and exercise period commencing immediately upon the earlier of shareholder approval or six months from the issuance date, and a term of eighteen months and five and one-half years. The transaction is expected to close on or about October 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3348 USD | +3.98% | +1.15% | -57.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.29% | 12.08M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- COEP Stock
- News Coeptis Therapeutics Holdings, Inc.
- Coeptis Therapeutics Holdings, Inc. announced that it expects to receive $2 million in funding